Skip to content

SOPHARMA

Active Public limited companyfounded 2001active for 24 yearsJezus Eiklaan 2A, 3080 TervurenKBO/BCE: BE 0476.391.546 #1 company by total assets in Tervuren, Wholesale and retail trade sector

Lifetime

20 annual accounts with figures on one time axis, 24 filings since 2002
peak of €430,273 in 2023
€113,036▼ 65.2%
lowest -€33,688 in 2011
€14.3m▲ 15×
peak of €167.3m in 2025
€167.3m▲ 213%
€4.8m▲ 493%
peak of 3.3 FTE in 2019
1.5 FTE▼ 40.0%
Board2 names since 2009
1 director
Documentsfilings and deeds
30-07-20261 day before the deadline
2025abbreviated format
Gross margin from €324,951 to €113,036Result from €965,281 to €14.3mStaff from 2.5 FTE to 1.5 FTECapital increase · Resignations & appointments 22-07Merger: SOPHARMA takes over SOLOBA 22-07Merger: SOPHARMA takes over Excelsus NV 22-07

Key points

from the 2025 annual accounts

Equity

€167.3m ▲ 213%

SOPHARMA has made a profit without a break since 2012.

Result

€14.3m ▲ 15×
€965,0002024€14m2025

The result rose in 2025: merger with EXCELSUS.

Debts

€4.8m ▲ 493%
Other debts
+2.1
Financial debts
+1.7
Suppliers
+0.04
The rest
+0.2

Debts rose by €4.0m in 2025. A dividend stands under other debts on the balance sheet date until it is paid.

Staff

2 employees on 31-12-2025
112022242023522024132025

In 2025, 1 employee joined and 3 left.

Liquidity

14.29 was 4.95 in 2024

Short-term debts rose from €494,248 to €2.6m.

Restructuring

2

SOPHARMA went through 2 restructurings since 2025. On 22-07-2025, SOPHARMA took over EXCELSUS by merger.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Managing director
Director,
  • deed of 22-07-2025

Shares in 2 companies, and

Board & ownership

Recent changes

reappointed as managing director acts as permanent representative · General meeting of 30-06-2026 · Gazette deed
Registered in the Peppol Directory Reachable for e-invoices through 0208:0476391546
Capital increase · Resignations & appointments The capital rose from €45,057,000 to €47,452,056.48, with 256 new shares · The capital rose from €47,452,056.48 to €52,796,681.99 · is a shareholder · General meeting of 30-06-2025 · Gazette deed
Merger: SOPHARMA takes over SOLOBA Capital increase of €583.95 to €45,057,000 · The capital rose from €45,056,416.05 to €45,057,000 · The company holds all the shares of SOLOBA · General meeting of 30-06-2025 · Gazette deed
All 51 events

Comparable companies

same main activity, similar in size and age
Company
SOPHARMA Tervuren - - 97.2% 1.5
VERTEX PHARMACEUTICALS (BELGIUM) Brussels €88.9m 2.9% 4.1% 13.2
BENU Management Wavre €9.5m 35.4% 31.3% 27.2
MEES MANAGEMENT APOTHEEK Sint-Truiden €4.2m 52.8% 56.3% 18
DMBB Enghien - - 25.5% 1.8
SODIAP Izegem €5.3m 31.3% 41.0% 37.9
PHARMA BASE Genk €75.2m 0.5% 12.0% 29

These companies have the same main activity as SOPHARMA: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €21m and €163m, founded between 1967 and 2022.

Official details

Source: KBO
Status
Active since 20-12-2001Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730and 1 other
Joint committee
313Pharmacies and pricing offices · annual accounts 2021
Establishment unit
2.095.660.5513080 Tervuren, since 15-02-2002
Financial year end
31 December
Peppol
Reachable since 23-10-2025
Company details

Annual accounts 2025

≈ €530,000estimated
€172.1m▲ 217%
Employeeson 31-12-2025
2▼ 50.0%
Filing
Filed on 30-07-2026, 1 day before the end of the filing period
Financials

Insights on SOPHARMA

SOPHARMA files the abbreviated format. That format states no turnover. The gross margin fell from €204,375 in 2006 to €113,036 in 2025.

In October 2026, the Official Gazette published the appointment of as managing director.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about SOPHARMA

What is the company number of SOPHARMA?
The company number of SOPHARMA is 0476.391.546. The VAT number is the same number with BE in front: BE 0476.391.546.
Where is SOPHARMA based?
The registered office is at Jezus Eiklaan 2A, 3080 Tervuren.Company details
What does SOPHARMA do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of SOPHARMA?
SOPHARMA is a public limited company (NV).
When was SOPHARMA founded?
SOPHARMA was founded on 20-12-2001.
Is SOPHARMA still active?
Yes, SOPHARMA is an active enterprise in the KBO register.
How many employees does SOPHARMA have?
SOPHARMA had an average of 1.5 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does SOPHARMA fall under?
In its 2021 annual accounts, SOPHARMA states joint committee 313 (Pharmacies and pricing offices).
What is the turnover of SOPHARMA?
The turnover in financial year 2025 is about €530,000. This figure is estimated from the gross margin of €113,036 and 43 comparable companies (NACE 477). It probably lies between €350,000 and €1.1m.
Is SOPHARMA profitable?
In financial year 2025, SOPHARMA made a profit of €14.3m.
Where can I find the annual accounts of SOPHARMA?
SOPHARMA filed 24 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of SOPHARMA due?
SOPHARMA must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.